MedPath

Impact of Energy Drink Brands on Heart Rhythm

Not Applicable
Completed
Conditions
Blood Pressure
Electrical Alternation of Heart
Interventions
Other: Placebo
Dietary Supplement: Energy Drink Brand 1
Dietary Supplement: Energy Drink Brand 2
Registration Number
NCT03196908
Lead Sponsor
University of the Pacific
Brief Summary

To assess the cardiac effects of energy drink brands in healthy volunteers

Detailed Description

Energy drinks are widely available and globally consumed. There are many brands of energy drinks on the market, and there are differences in the ingredients included. Previous studies have tried to evaluate the safety of energy drinks and have demonstrated a signal for some electrocardiographic (ECG) and hemodynamic effects. However, product related differences need further exploration. This study is designed to assess the effects of 2 different energy drink products on heart rhythm and blood pressure in healthy subjects.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Healthy male or female adults 18 - 40 years old
  • Participants must be willing to refrain from caffeine and alcohol use ≥48 hours prior to sessions on Day 1, 8, and 15
Exclusion Criteria
  • Presence of any known medical condition confirmed through participant interview
  • QTc interval greater than 450 milliseconds (ms).
  • Blood pressure greater than 140/90 mmHg.
  • Current smokers
  • Concurrent use of prescription, over-the-counter (OTC) or herbal supplements taken on a daily basis (except oral contraceptives).
  • Pregnant or currently breast-feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboTwo 16-oz bottles that each contain 390 ml of carbonated water, 20 ml of reconstituted lime juice, and 70 ml of cherry flavoring
Energy Drink Brand 1Energy Drink Brand 1Two 16-oz bottles of Energy Drink Brand 1
Energy Drink Brand 2Energy Drink Brand 2Two 16-oz bottles of Energy Drink Brand 2
Primary Outcome Measures
NameTimeMethod
Corrected QT (QTc) Interval4 hours

Electrocardiograph (ECG) Parameters

Secondary Outcome Measures
NameTimeMethod
QT4 hours

Electrocardiograph (ECG) Parameters

Heart Rate (HR)4 hours

Electrocardiograph (ECG) Parameters

Peripheral blood pressure4 hours

Hemodynamic Parameters

PR4 hours

Electrocardiograph (ECG)Parameters

Central blood pressure4 hours

Hemodynamic Parameters

QRS4 hours

Electrocardiograph (ECG) Parameters

Trial Locations

Locations (1)

University of the Pacific

🇺🇸

Stockton, California, United States

© Copyright 2025. All Rights Reserved by MedPath